US Stock MarketDetailed Quotes

Iterum Therapeutics (ITRM)

Watchlist
  • 0.3403
  • +0.0183+5.68%
Close Jan 16 16:00 ET
  • 0.3500
  • +0.0097+2.85%
Post 20:01 ET
18.14MMarket Cap-0.47P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Iterum Therapeutics (ITRM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-178.71%-7.45M
29.71%-4.75M
76.61%-3.06M
31.93%-26.77M
66.86%-4.26M
71.16%-2.67M
11.44%-6.76M
-36.42%-13.08M
-112.91%-39.33M
-201.13%-12.84M
Net income from continuing operations
-47.34%-8.98M
-30.26%-6.51M
31.12%-4.89M
35.44%-24.77M
46.76%-6.58M
-57.18%-6.09M
59.18%-5M
28.19%-7.1M
13.64%-38.37M
-142.87%-12.36M
Operating gains losses
55.43%673K
43.73%585K
42.23%549K
129.57%3.27M
569.84%2.04M
103.28%433K
-57.60%407K
-56.04%386K
-102.57%-11.06M
110.30%305K
Depreciation and amortization
4,337.50%355K
4,287.50%351K
4,885.71%349K
-83.77%284K
-40.68%261K
-98.17%8K
-98.17%8K
-98.39%7K
-2.78%1.75M
0.23%440K
Other non cash items
-51.71%1.44M
-24.13%937K
-8.59%1.14M
20.62%7.17M
-17.83%1.71M
130.05%2.99M
-1.98%1.24M
-5.11%1.25M
10.44%5.95M
188.60%2.08M
Change In working capital
-1,257.53%-991K
95.09%-171K
96.57%-266K
-560.77%-12.73M
38.13%-1.42M
-101.23%-73K
-288.82%-3.48M
-185.22%-7.76M
19.56%2.76M
-197.54%-2.3M
-Change in inventory
---201K
---415K
---533K
----
----
--0
--0
--0
----
----
-Change in prepaid assets
27.22%-984K
25.53%-1.08M
-158.85%-133K
16.47%-2.66M
85.99%-88K
-900.00%-1.35M
-12.85%-1.45M
115.64%226K
-105.54%-3.19M
-428.80%-628K
-Change in payables and accrued expense
-41.29%731K
206.08%1.85M
104.89%388K
-272.53%-9.86M
21.20%-1.42M
-78.40%1.25M
-157.32%-1.74M
-516.39%-7.93M
12.44%5.71M
-183.97%-1.81M
-Change in other current assets
----
----
----
-94.72%17K
----
----
----
----
--322K
----
-Change in other current liabilities
--0
-425.25%-520K
52.00%-48K
-8.76%-385K
14.29%-84K
-96.15%-102K
2.94%-99K
1.96%-100K
50.00%-354K
2.00%-98K
-Change in other working capital
----
96.83%-6K
22.45%60K
-42.80%155K
----
----
-200.53%-189K
-57.02%49K
153.14%271K
----
Cash from discontinued investing activities
Operating cash flow
-178.71%-7.45M
29.71%-4.75M
76.61%-3.06M
31.93%-26.77M
66.86%-4.26M
71.16%-2.67M
11.44%-6.76M
-36.42%-13.08M
-112.91%-39.33M
-201.13%-12.84M
Investing cash flow
Cash flow from continuing investing activities
-100.21%-12K
0
-100.03%-2K
-21.97%18.21M
-91.87%1.1M
1,483.33%5.7M
-3.45%4.2M
41.23%7.21M
67.20%23.34M
208.89%13.52M
Net PPE purchase and sale
---12K
--0
---2K
84.62%-2K
--0
--0
---2K
--0
79.03%-13K
--0
Net investment purchase and sale
--0
--0
--0
-22.01%18.21M
-91.87%1.1M
1,496.64%5.7M
-3.76%4.2M
41.23%7.21M
66.55%23.35M
205.74%13.52M
Cash from discontinued investing activities
Investing cash flow
-100.21%-12K
--0
-100.03%-2K
-21.97%18.21M
-91.87%1.1M
1,483.33%5.7M
-3.45%4.2M
41.23%7.21M
67.20%23.34M
208.89%13.52M
Financing cash flow
Cash flow from continuing financing activities
0.04%5.43M
2,965.87%5.12M
-216.23%-8.39M
2,481.33%26.69M
2,256.03%13.88M
54,200.00%5.43M
-16.50%167K
2,971.06%7.22M
156.88%1.03M
36.03%589K
Net issuance payments of debt
--0
----
----
--0
--0
--0
----
----
--0
----
Net common stock issuance
0.04%5.43M
2,965.87%5.12M
-11.92%6.36M
2,481.33%26.69M
2,256.03%13.88M
54,200.00%5.43M
-16.50%167K
2,971.06%7.22M
138.80%1.03M
36.03%589K
Net other financing activities
----
----
---14.75M
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
0.04%5.43M
2,965.87%5.12M
-216.23%-8.39M
2,481.33%26.69M
2,256.03%13.88M
54,200.00%5.43M
-16.50%167K
2,971.06%7.22M
156.88%1.03M
36.03%589K
Net cash flow
Beginning cash position
160.68%13.06M
70.90%12.69M
295.72%24.16M
-71.10%6.11M
177.11%13.44M
-63.61%5.01M
-55.99%7.42M
-71.10%6.11M
-23.21%21.13M
-76.40%4.85M
Current changes in cash
-123.97%-2.03M
115.41%369K
-951.30%-11.45M
221.18%18.13M
744.84%10.72M
195.09%8.46M
22.37%-2.4M
131.65%1.35M
-136.19%-14.96M
132.42%1.27M
Effect of exchange rate changes
92.86%-2K
127.78%5K
14.81%-23K
-22.95%-75K
85.71%-2K
-21.74%-28K
-50.00%-18K
-125.00%-27K
-22.00%-61K
-151.85%-14K
End cash Position
-17.92%11.03M
160.68%13.06M
70.90%12.69M
295.72%24.16M
295.72%24.16M
177.11%13.44M
-63.61%5.01M
-55.99%7.42M
-71.10%6.11M
-71.10%6.11M
Free cash flow
-179.15%-7.46M
29.73%-4.75M
76.60%-3.06M
31.95%-26.77M
66.86%-4.26M
71.15%-2.67M
11.60%-6.76M
-36.42%-13.08M
-112.26%-39.34M
-197.98%-12.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -178.71%-7.45M29.71%-4.75M76.61%-3.06M31.93%-26.77M66.86%-4.26M71.16%-2.67M11.44%-6.76M-36.42%-13.08M-112.91%-39.33M-201.13%-12.84M
Net income from continuing operations -47.34%-8.98M-30.26%-6.51M31.12%-4.89M35.44%-24.77M46.76%-6.58M-57.18%-6.09M59.18%-5M28.19%-7.1M13.64%-38.37M-142.87%-12.36M
Operating gains losses 55.43%673K43.73%585K42.23%549K129.57%3.27M569.84%2.04M103.28%433K-57.60%407K-56.04%386K-102.57%-11.06M110.30%305K
Depreciation and amortization 4,337.50%355K4,287.50%351K4,885.71%349K-83.77%284K-40.68%261K-98.17%8K-98.17%8K-98.39%7K-2.78%1.75M0.23%440K
Other non cash items -51.71%1.44M-24.13%937K-8.59%1.14M20.62%7.17M-17.83%1.71M130.05%2.99M-1.98%1.24M-5.11%1.25M10.44%5.95M188.60%2.08M
Change In working capital -1,257.53%-991K95.09%-171K96.57%-266K-560.77%-12.73M38.13%-1.42M-101.23%-73K-288.82%-3.48M-185.22%-7.76M19.56%2.76M-197.54%-2.3M
-Change in inventory ---201K---415K---533K----------0--0--0--------
-Change in prepaid assets 27.22%-984K25.53%-1.08M-158.85%-133K16.47%-2.66M85.99%-88K-900.00%-1.35M-12.85%-1.45M115.64%226K-105.54%-3.19M-428.80%-628K
-Change in payables and accrued expense -41.29%731K206.08%1.85M104.89%388K-272.53%-9.86M21.20%-1.42M-78.40%1.25M-157.32%-1.74M-516.39%-7.93M12.44%5.71M-183.97%-1.81M
-Change in other current assets -------------94.72%17K------------------322K----
-Change in other current liabilities --0-425.25%-520K52.00%-48K-8.76%-385K14.29%-84K-96.15%-102K2.94%-99K1.96%-100K50.00%-354K2.00%-98K
-Change in other working capital ----96.83%-6K22.45%60K-42.80%155K---------200.53%-189K-57.02%49K153.14%271K----
Cash from discontinued investing activities
Operating cash flow -178.71%-7.45M29.71%-4.75M76.61%-3.06M31.93%-26.77M66.86%-4.26M71.16%-2.67M11.44%-6.76M-36.42%-13.08M-112.91%-39.33M-201.13%-12.84M
Investing cash flow
Cash flow from continuing investing activities -100.21%-12K0-100.03%-2K-21.97%18.21M-91.87%1.1M1,483.33%5.7M-3.45%4.2M41.23%7.21M67.20%23.34M208.89%13.52M
Net PPE purchase and sale ---12K--0---2K84.62%-2K--0--0---2K--079.03%-13K--0
Net investment purchase and sale --0--0--0-22.01%18.21M-91.87%1.1M1,496.64%5.7M-3.76%4.2M41.23%7.21M66.55%23.35M205.74%13.52M
Cash from discontinued investing activities
Investing cash flow -100.21%-12K--0-100.03%-2K-21.97%18.21M-91.87%1.1M1,483.33%5.7M-3.45%4.2M41.23%7.21M67.20%23.34M208.89%13.52M
Financing cash flow
Cash flow from continuing financing activities 0.04%5.43M2,965.87%5.12M-216.23%-8.39M2,481.33%26.69M2,256.03%13.88M54,200.00%5.43M-16.50%167K2,971.06%7.22M156.88%1.03M36.03%589K
Net issuance payments of debt --0----------0--0--0----------0----
Net common stock issuance 0.04%5.43M2,965.87%5.12M-11.92%6.36M2,481.33%26.69M2,256.03%13.88M54,200.00%5.43M-16.50%167K2,971.06%7.22M138.80%1.03M36.03%589K
Net other financing activities -----------14.75M----------------------------
Cash from discontinued financing activities
Financing cash flow 0.04%5.43M2,965.87%5.12M-216.23%-8.39M2,481.33%26.69M2,256.03%13.88M54,200.00%5.43M-16.50%167K2,971.06%7.22M156.88%1.03M36.03%589K
Net cash flow
Beginning cash position 160.68%13.06M70.90%12.69M295.72%24.16M-71.10%6.11M177.11%13.44M-63.61%5.01M-55.99%7.42M-71.10%6.11M-23.21%21.13M-76.40%4.85M
Current changes in cash -123.97%-2.03M115.41%369K-951.30%-11.45M221.18%18.13M744.84%10.72M195.09%8.46M22.37%-2.4M131.65%1.35M-136.19%-14.96M132.42%1.27M
Effect of exchange rate changes 92.86%-2K127.78%5K14.81%-23K-22.95%-75K85.71%-2K-21.74%-28K-50.00%-18K-125.00%-27K-22.00%-61K-151.85%-14K
End cash Position -17.92%11.03M160.68%13.06M70.90%12.69M295.72%24.16M295.72%24.16M177.11%13.44M-63.61%5.01M-55.99%7.42M-71.10%6.11M-71.10%6.11M
Free cash flow -179.15%-7.46M29.73%-4.75M76.60%-3.06M31.95%-26.77M66.86%-4.26M71.15%-2.67M11.60%-6.76M-36.42%-13.08M-112.26%-39.34M-197.98%-12.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -